₹1,347.40 ($14.00)

-2.20 (-0.16%)

NSE · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 41 · ₹61.5B mcap · 20M float · 1.56% daily turnover

View Full Income Statement

No data available

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$983M	$1.0B	$988M	$1.3B	$1.5B	$1.6B	$1.8B	$1.8B
Cost of Revenue	$479M	$407M	$665M	$614M	$571M	$670M	$662M	$1.1B
Gross Profit	$503M	$623M	$322M	$689M	$963M	$978M	$1.1B	$746M
Gross Margin	51.2%	60.5%	32.6%	52.9%	62.8%	59.3%	62.2%	41.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$0	$0	$0	$0	$0	$0	$0	$308M
Operating Expenses	$310M	$408M	$181M	$408M	$549M	$517M	$708M	$308M
Operating Income	$194M	$215M	$142M	$282M	$414M	$461M	$382M	$438M
Operating Margin	19.7%	20.9%	14.3%	21.6%	27.0%	28.0%	21.8%	24.3%
Interest Expense	$53M	$62M	$41M	$50M	$62M	$53M	$85M	$72M
Income Before Tax	$160M	$205M	$207M	$265M	$406M	$446M	$474M	$395M
Tax Expense	$29M	$41M	$27M	$53M	$105M	$110M	$107M	$90M
Net Income	$128M	$172M	$178M	$197M	$324M	$317M	$316M	$307M
Net Margin	13.1%	16.7%	18.1%	15.1%	21.1%	19.2%	18.0%	17.0%
EPS (Diluted)	$2.79	$5.04	$0.00	$4.60	$6.54	$7.29	$7.96	$6.60
EBITDA	$251M	$308M	$300M	$375M	$549M	$578M	$652M	$538M
Shares Outstanding	46M	34M	0	43M	50M	43M	40M	47M

SENORES.NS NSE